These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 36242051)
81. A novel RORγt inhibitor is a potential therapeutic agent for the topical treatment of psoriasis with low risk of thymic aberrations. Imura C; Ueyama A; Sasaki Y; Shimizu M; Furue Y; Tai N; Tsujii K; Katayama K; Okuno T; Shichijo M; Yasui K; Yamamoto M J Dermatol Sci; 2019 Mar; 93(3):176-185. PubMed ID: 30905492 [TBL] [Abstract][Full Text] [Related]
82. Oxidative stress involvement in psoriasis: a systematic review. Cannavò SP; Riso G; Casciaro M; Di Salvo E; Gangemi S Free Radic Res; 2019 Aug; 53(8):829-840. PubMed ID: 31392915 [TBL] [Abstract][Full Text] [Related]
83. A double-edged sword: ROS related therapies in the treatment of psoriasis. Hu J; Bian Q; Ma X; Xu Y; Gao J Asian J Pharm Sci; 2022 Nov; 17(6):798-816. PubMed ID: 36600897 [TBL] [Abstract][Full Text] [Related]
84. Epidermal barrier and oxidative stress parameters improve during in 311 nm narrow band UVB phototherapy of plaque type psoriasis. Darlenski R; Hristakieva E; Aydin U; Gancheva D; Gancheva T; Zheleva A; Gadjeva V; Fluhr JW J Dermatol Sci; 2018 Jul; 91(1):28-34. PubMed ID: 29610017 [TBL] [Abstract][Full Text] [Related]
85. Treatment of psoriatic arthritis with antitumour necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate. Ogilvie AL; Antoni C; Dechant C; Manger B; Kalden JR; Schuler G; Lüftl M Br J Dermatol; 2001 Mar; 144(3):587-9. PubMed ID: 11260020 [TBL] [Abstract][Full Text] [Related]
86. Astilbin reduces ROS accumulation and VEGF expression through Nrf2 in psoriasis-like skin disease. Wang W; Yuhai ; Wang H; Chasuna ; Bagenna Biol Res; 2019 Sep; 52(1):49. PubMed ID: 31492195 [TBL] [Abstract][Full Text] [Related]
87. Tussilagonone Ameliorates Psoriatic Features in Keratinocytes and Imiquimod-Induced Psoriasis-Like Lesions in Mice via NRF2 Activation. Lee J; Song K; Hiebert P; Werner S; Kim TG; Kim YS J Invest Dermatol; 2020 Jun; 140(6):1223-1232.e4. PubMed ID: 31877316 [TBL] [Abstract][Full Text] [Related]
88. Proteomic analysis of psoriatic skin tissue for identification of differentially expressed proteins: up-regulation of GSTP1, SFN and PRDX2 in psoriatic skin. Ryu J; Park SG; Park BC; Choe M; Lee KS; Cho JW Int J Mol Med; 2011 Nov; 28(5):785-92. PubMed ID: 21805023 [TBL] [Abstract][Full Text] [Related]
89. Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters. Heng MC; Song MK; Harker J; Heng MK Br J Dermatol; 2000 Nov; 143(5):937-49. PubMed ID: 11069500 [TBL] [Abstract][Full Text] [Related]
90. Decreased expression of G-protein-coupled receptors GPR43 and GPR109a in psoriatic skin can be restored by topical application of sodium butyrate. Krejner A; Bruhs A; Mrowietz U; Wehkamp U; Schwarz T; Schwarz A Arch Dermatol Res; 2018 Nov; 310(9):751-758. PubMed ID: 30209581 [TBL] [Abstract][Full Text] [Related]
91. The antipsoriatic agent monomethylfumarate has antiproliferative, prodifferentiative, and anti-inflammatory effects on keratinocytes. Helwa I; Patel R; Karempelis P; Kaddour-Djebbar I; Choudhary V; Bollag WB J Pharmacol Exp Ther; 2015 Jan; 352(1):90-7. PubMed ID: 25332455 [TBL] [Abstract][Full Text] [Related]
92. Molecular action of isoflavone genistein in the human epithelial cell line HaCaT. Smolińska E; Moskot M; Jakóbkiewicz-Banecka J; Węgrzyn G; Banecki B; Szczerkowska-Dobosz A; Purzycka-Bohdan D; Gabig-Cimińska M PLoS One; 2018; 13(2):e0192297. PubMed ID: 29444128 [TBL] [Abstract][Full Text] [Related]
93. Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy. Rahman M; Akhter S; Ahmad J; Ahmad MZ; Beg S; Ahmad FJ Expert Opin Drug Deliv; 2015 Apr; 12(4):635-52. PubMed ID: 25439967 [TBL] [Abstract][Full Text] [Related]
94. Psoriasis clinical implications and treatment: a review. Raut AS; Prabhu RH; Patravale VB Crit Rev Ther Drug Carrier Syst; 2013; 30(3):183-216. PubMed ID: 23614646 [TBL] [Abstract][Full Text] [Related]
96. Research Techniques Made Simple: Murine Models of Human Psoriasis. Hawkes JE; Adalsteinsson JA; Gudjonsson JE; Ward NL J Invest Dermatol; 2018 Jan; 138(1):e1-e8. PubMed ID: 29273150 [TBL] [Abstract][Full Text] [Related]
97. Role of Apoptotic-targeted Phytoconstitutent-loaded Antipsoriatic Nanobiocomposites. Singh Patel P; Srivastava R; Panchawat S Recent Pat Nanotechnol; 2024; 18(2):220-236. PubMed ID: 36725825 [TBL] [Abstract][Full Text] [Related]
98. Research Hotspots in Psoriasis: A Bibliometric Study of the Top 100 Most Cited Articles. Tiucă OM; Morariu SH; Mariean CR; Tiucă RA; Nicolescu AC; Cotoi OS Healthcare (Basel); 2023 Jun; 11(13):. PubMed ID: 37444683 [TBL] [Abstract][Full Text] [Related]
99. Transcriptome analysis based on machine learning reveals a role for autoinflammatory genes of chronic nonbacterial osteomyelitis (CNO). Fu Z; Wang X; Zou L; Zhang Z; Lu M; Zong J; Wang S Sci Rep; 2023 Apr; 13(1):6514. PubMed ID: 37085667 [TBL] [Abstract][Full Text] [Related]